Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants
- PMID: 22174611
- PMCID: PMC3233417
- DOI: 10.3390/ijms12117469
Development of a human Physiologically Based Pharmacokinetic (PBPK) Toolkit for environmental pollutants
Abstract
Physiologically Based Pharmacokinetic (PBPK) models can be used to determine the internal dose and strengthen exposure assessment. Many PBPK models are available, but they are not easily accessible for field use. The Agency for Toxic Substances and Disease Registry (ATSDR) has conducted translational research to develop a human PBPK model toolkit by recoding published PBPK models. This toolkit, when fully developed, will provide a platform that consists of a series of priority PBPK models of environmental pollutants. Presented here is work on recoded PBPK models for volatile organic compounds (VOCs) and metals. Good agreement was generally obtained between the original and the recoded models. This toolkit will be available for ATSDR scientists and public health assessors to perform simulations of exposures from contaminated environmental media at sites of concern and to help interpret biomonitoring data. It can be used as screening tools that can provide useful information for the protection of the public.
Keywords: National Health and Nutrition Examination Survey (NHANES); PBPK; VOCs; metals; toxicokinetic; volatile organic compounds.
Figures


Similar articles
-
Translational research to develop a human PBPK models tool kit-volatile organic compounds (VOCs).J Toxicol Environ Health A. 2012;75(1):6-24. doi: 10.1080/15287394.2012.625546. J Toxicol Environ Health A. 2012. PMID: 22047160 Free PMC article.
-
Physiologically based pharmacokinetic (PBPK) tool kit for environmental pollutants--metals.SAR QSAR Environ Res. 2010 Oct;21(7-8):603-18. doi: 10.1080/1062936X.2010.528942. SAR QSAR Environ Res. 2010. PMID: 21120752
-
Chemical-specific screening criteria for interpretation of biomonitoring data for volatile organic compounds (VOCs)--application of steady-state PBPK model solutions.Regul Toxicol Pharmacol. 2010 Oct;58(1):33-44. doi: 10.1016/j.yrtph.2010.05.011. Epub 2010 Jun 1. Regul Toxicol Pharmacol. 2010. PMID: 20685286
-
Approaches for applications of physiologically based pharmacokinetic models in risk assessment.J Toxicol Environ Health B Crit Rev. 2008 Aug;11(7):519-47. doi: 10.1080/10937400701724337. J Toxicol Environ Health B Crit Rev. 2008. PMID: 18584453 Review.
-
An overview of human exposure modeling activities at the USEPA's National Exposure Research Laboratory.Toxicol Ind Health. 2001 Jun;17(5-10):302-14. doi: 10.1191/0748233701th107oa. Toxicol Ind Health. 2001. PMID: 12539877 Review.
Cited by
-
Physiologically Based Pharmacokinetic Modeling of Extracellular Vesicles.Biology (Basel). 2023 Aug 29;12(9):1178. doi: 10.3390/biology12091178. Biology (Basel). 2023. PMID: 37759578 Free PMC article. Review.
-
Physiologically based pharmacokinetic toolkit to evaluate environmental exposures: Applications of the dioxin model to study real life exposures.Toxicol Appl Pharmacol. 2017 Jan 15;315:70-79. doi: 10.1016/j.taap.2016.12.007. Epub 2016 Dec 10. Toxicol Appl Pharmacol. 2017. PMID: 27956220 Free PMC article.
-
Exploring Mechanistic Toxicity of Mixtures Using PBPK Modeling and Computational Systems Biology.Toxicol Sci. 2020 Mar 1;174(1):38-50. doi: 10.1093/toxsci/kfz243. Toxicol Sci. 2020. PMID: 31851354 Free PMC article.
-
Estimation of health risks associated with dietary cadmium exposure.Arch Toxicol. 2023 Feb;97(2):329-358. doi: 10.1007/s00204-022-03432-w. Epub 2023 Jan 2. Arch Toxicol. 2023. PMID: 36592197 Review.
-
Assessing the Application of Physiologically Based Pharmacokinetic Models in Acute Chemical Incidents.J Xenobiot. 2025 Mar 11;15(2):42. doi: 10.3390/jox15020042. J Xenobiot. 2025. PMID: 40126260 Free PMC article.
References
-
- Reddy M., Yang R.S., Andersen M.E., Clewell H.J., III . Physiologically Based Pharmacokinetic Modeling: Science and Applications. John Wiley & Sons; New York, NY, USA: 2005.
-
- Zhao P., Zhang L., Grillo J.A., Liu Q., Bullock J.M., Moon Y.J., Song P., Brar S.S., Madabushi R., Wu T.C., et al. Applications of physiologically based pharmacokinetic (PBPK) modeling and simulation during regulatory review. Clin. Pharmacol. Ther. 2011;89:259–267. - PubMed
-
- Thompson C.M., Sonawane B., Barton H.A., DeWoskin R.S., Lipscomb J.C., Schlosser P., Chiu W.A., Krishnan K. Approaches for applications of physiologically based pharmacokinetic models in risk assessment. J. Toxicol. Environ. Health B Crit. Rev. 2008;11:519–547. - PubMed
-
- Valcke M., Krishnan K. Evaluation of the impact of the exposure route on the human kinetic adjustment factor. Regul. Toxicol. Pharmacol. 2011;59:258–269. - PubMed
-
- Krishnan K., Carrier R. Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 2008;26:300–316. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources